Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Journal of Neurochemistry|January 18, 2006
Substrate-mediated enhancement of phosphorylated tyrosine hydroxylase in nigrostriatal dopamine neurons: evidence for a role of alpha-synucleinRobert E Drolet, Bahareh Behrouz, Keith J Lookingland, et al.
Neurotoxicology|August 4, 2004
Mice lacking alpha-synuclein have an attenuated loss of striatal dopamine following prolonged chronic MPTP administrationRobert E Drolet, Bahareh Behrouz, Keith J Lookingland, et al.
Neurobiology of Disease|July 15, 2009
Chronic rotenone exposure reproduces Parkinson's disease gastrointestinal neuropathologyRobert E Drolet, Jason R Cannon, Laura Montero, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 2, 2006
Alpha-synuclein induces hyperphosphorylation of Tau in the MPTP model of parkinsonismTetyana Duka, Milan Rusnak, Robert E Drolet, et al.
Neurobiology of Disease|April 23, 2009
A highly reproducible rotenone model of Parkinson's diseaseJason R Cannon, Victor Tapias, Hye Mee Na, et al.
Journal of Alzheimer'S Disease : JAD|September 11, 2008
Effects of sildenafil on nigrostriatal dopamine neurons in a murine model of Parkinson's diseaseKelly L Janis, Ryan T Brennan, Robert E Drolet, et al.
Journal of Neurochemistry|October 15, 2013
Non-motor parkinsonian pathology in aging A53T α-synuclein mice is associated with progressive synucleinopathy and altered enzymatic functionKaitlin F Farrell, Sesha Krishnamachari, Ernesto Villanueva, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 23, 2015
Internalized Tau Oligomers Cause Neurodegeneration by Inducing Accumulation of Pathogenic Tau in Human Neurons Derived from Induced Pluripotent Stem CellsMarija Usenovic, Shahriar Niroomand, Robert E Drolet, et al.
Human Molecular Genetics|July 2, 2019
Functionalization of the TMEM175 p.M393T variant as a risk factor for Parkinson diseaseSarah Jinn, Cornelis Blauwendraat, Dawn Toolan, et al.
Pageof 2